Trusted by generations of cardiologists for the latest, most reliable guidance in the field, Braunwald's Heart Disease, 11th Edition, remains your #1 source of information on rapidly changing clinical science, clinical and translational research, and evidence-based medicine. This award-winning text has been completely updated, providing a superior multimedia reference for every aspect of this fast-changing field, including new material about almost every topic in cardiology.
New to this Edition
A unique update program by Dr. Braunwald creates a "living textbook" by featuring weekly Hot off the Press, periodic Late-Breaking Clinical Trials (including links to authors' presentation slides), and monthly Focused Reviews.
More than a dozen new chapters cover Chronic Lung Disorders and Cardiovascular Disease; Transcatheter Treatment of Congenital Heart Disease; Approach to the Patient with Valvular Heart Disease; Obesity and Cardiometabolic Disease; Environmental Exposures and CVD; Approach to the Patient with Cardiac Arrhythmias; Cardio-oncology, Precision Medicine, and more.
New information on clinical cardiovascular genetics; MR PET; MR device compatibility; fibrosis; fusion imaging; OCT; IVUS; left atrial appendage exclusion approaches and other topics.
Many new videos that elucidate coronary, peripheral, valvular, congenital heart diseases and other cardiovascular diseases.
Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Author Information
By Douglas P. Zipes, MD, Distinguished Professor, Emeritus Professor of Medicine, Pharmacology, and Toxicology, Emeritus Director, Division of Cardiology and the Krannert Institute of Cardiology, Indiana University School of Medicine, Editor-in-Chief, PracticeUpdate/Cardiology, Editor-in-Chief, Trends in Cardiovascular Medicine, Indianapolis, IN; Peter Libby, MD, PhD, Chief, Cardiovascular Medicine, Brigham and Women's Hospital; Mallinckrodt Professor of Medicine, Harvard Medical School; Reynolds Investigator and Co-Director, Donald W. Reynolds Cardiovascular Clinical Research Center, Brigham and Women's Hospital, Boston, MA; Robert O. Bonow, MD, MS, Goldberg Distinguished Professor of Cardiology, Director, Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois; Douglas L. Mann, MD, Lewin Chair and Professor of Medicine, Cell Biology, and Physiology, Chief, Cardiovascular Division, Washington University School of Medicine; Cardiologist-in-Chief, Barnes-Jewish Hospital, St. Louis, Missouri and Gordon F. Tomaselli, MD, Chief, Division of Cardiology; Professor of Medicine, Johns Hopkins Univerusty, Baltimore, Maryland
1 PL Global Burden of Cardiovascular Disease
2 DZ Ethical Decisions in Cardiovascular Medicine
3 DZ Clinical Decision Making in Cardiology
4 RB Measurement and Improvement of Quality of Care: Relevance to Cardiovascular Clinical Practice
5 DM Critical Evaluation of Clinical Trials
6 PL Personalized and Precision Cardiovascular Medicine
7 PL Principles of Cardiovascular Genetics
8 DZ Drug Therapeutics and Personalized Medicine
9 PL Biomarkers and Their Use in Precision Medicine
10 PL The History and Physical Examination: An Evidence-Based Approach
11 PL Evaluation and Management of the Noncardiac Surgical Patient-
12 DZ Electrocardiography
13 RB Exercise Testing
14 RB Echocardiography
Appropriate Use Criteria: Echocardiography
15 RB The Chest Radiograph in Cardiovascular Disease
16 RB Nuclear Cardiology
17 Cardiovascular Magnetic Resonance
18 Cardiac Computed Tomography
Appopriate Use Criteria: Multimodality Imaging in Stable Ischemic Heart Disease and Heart Failure
19 RB Cardiac Catheterization
20 Coronary Angiography and Intracoronary Imaging
21 DM Approach to the Patient With Heart Failure
22 DM Mechanisms of Cardiac Contraction and Relaxation
23 DM Pathophysiology of Heart Failure
24 DM Diagnosis and Management of Acute Heart Failure
Guidelines: The Hospitalized Patient With Heart Failure
25 DM Management of Patients With Heart Failure With Reduced Ejection Fraction
Guidelines: Management of Heart Failure with a Reduced Ejection Fraction
26 DM Heart Failure with a Preserved Ejection Fraction
Guidelines: Heart Failure with a Preserved Ejection Fraction
27 DM Devices for Monitoring and Managing Heart Failure
Guidelines: Cardiac Resynchronization Therapy and Implantable Cardioverter- Defibrillators for Heart Failure with a Reduced Ejection Fraction
28 DM Surgical Management of Heart Failure
29 DM Mechanical Circulatory Support
30 DM Cardiovascular Regeneration and Repair
31 DM Management of Patients with Advanced Heart Failure
32 DZ Approach to the Patient with Cardiac Arrhythmias
33 DZ Genetics of Cardiac Arrhythmias
34 DZ Mechanisms of Cardiac Arrhythmias
35 DZ Diagnosis of Cardiac Arrhythmias
Guidelines: Ambulatory Electrocardiographic and Electrophysiological Testing
36 DZ General Therapy for Cardiac Arrhythmias
37 DZ Supraventricular Arrhythmias
38 DZ Atrial Fibrillation: Clinical Features, Mechanisms, and Management
Guidelines: Atrial Fibrillation
39 DZ Ventricular Arrhythmias
40 DZ Bradycardia Arrhythmias
41 DZ Pacemakers and Implantable Cardioverter-Defibrillators
Guidelines: Cardiac Pacemakers and Cardioverter-Defibrillators
42 DZ Cardiac Arrest and Sudden Cardiac Death
43 DZ Hypotension and Syncope
Guidelines
44 PL The Vascular Biology of Atherosclerosis
45 PL Risk Markers and the Primary Prevention of Cardiovascular Disease
46 PL Systemic Hypertension: Mechanisms and Diagnosis
47 PL Systemic Hypertension: Management
Guidelines: Treatment of Hypertension
48 PL Lipid Disorders and Cardiovascular Disease
Guidelines: Management of Lipids
49 PL Nutrition and Cardiometabolic Diseases
50 Obesity and Cardiometabolic Disease
51 Diabetes and the Cardiovascular System
Guidelines: Diabetes and Heart Disease
52 RB Environmental Exposures and CVD
53 PL Exercise and Sports Cardiology
54 PL Comprehensive Cardiac Rehabilitation
55 DZ Complementary Approaches to Heart Disease Management
56 PL Approach to the Patient with Chest Pain
57 RB Coronary Blood Flow and Myocardial Ischemia
58 PL ST-Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features
59 PL ST-Elevation Myocardial Infarction: Management
Guidelines: Management of Patients with ST-Elevation Myocardial Infarction
60 PL Non-ST Elevation Acute Coronary Syndromes
Guidelines: Unstable Angina and Non-ST Elevation Myocardial Infarction
61 RB Stable Ischemic Heart Disease
Guidelines: Stable Ischemic Heart Disease
62 RB Percutaneous Coronary Intervention
Guidelines: Percutaneous Coronary Intervention
63 PL Diseases of the Aorta
Guidelines: Diseases of the Aorta
64 PL Peripheral Arterial Diseases
Guidelines: Peripheral Arterial Diseases
65 PL Prevention and Management of Ischemic Stroke
66 Treatment of Noncoronary Obstructive Vascular Disease
67 RB Approach to the Patient with VHD
68 RB Aortic Valve Disease
69 RB Mitral Valve Disease
70 RB Tricuspid, Pulmonic, and Multivalvular Disease
71 RB Prosthetic Heart Valve
72 RB Transcatheter Therapies for Valvular Heart Disease
Guidelines
73 RB Cardiovascular Infections
Guidelines
74 RB Rheumatic Fever
75 DZ Congenital Heart Disease in the Adult and Pediatric Patient
Guidelines
76 DM Catheter-Based Treatment of Congenital Heart Disease
77 DM The Dilated, Restrictive, and Infiltrative Cardiomyopathies
78 DM Hypertrophic Cardiomyopathy
79 DM Myocarditis
80 DM Drug and Toxin-Induced Cardiomyopathies
81 DM Cardio-oncology
82 DZ Cardiovascular Abnormalities in HIV-Infected Individuals
83 DZ Pericardial Diseases
Traumatic Heart Disease
84 PL Pulmonary Embolism
85 RB Pulmonary Hypertension
86 DZ Chronic Lung Disorders and Cardiovascular Disease
87 DZ Sleep Disordered Breathing and Cardiovascular Disease
88 DZ Cardiovascular Disease in the Elderly
89 PL Cardiovascular Disease in Women
90 DZ Pregnancy and Heart Disease
Guidelines: Pregnancy and Heart Disease
91 RB Heart Disease in Varied Populations
92 PL Endocrine Disorders and Cardiovascular Disease
93 PL Hemostasis, Thrombosis, Fibrinolysis, and Cardiovascular Disease
94 PL Rheumatic Diseases and the Cardiovascular System
95 DM Tumors Affecting the Cardiovascular System
96 DZ Psychiatric and Behavioral Aspects of Cardiovascular Disease
97 DZ Neurologic Disorders and Cardiovascular Disease
98 PL Interface Between Renal and Cardiovascular Diseases
99 DZ Cardiovascular Manifestations of Autonomic Disorders
상품문의가 없습니다.
등록된 상품이 없습니다.
주문하신 책과 다른 책이 잘못 배송되었거나 배송된 도서가 파본인 경우, 도서를 아래의 두가지 방법 중 하나를 선택하여 반송해 주시면 됩니다.
택배 또는 우편등기를 통한 반송 오발송이나 파본된 책에 대한 내용을 고객센터(033-745-8879)나 반품 및 교환 문의를 통해 알려 주시고,
오발송/파본 도서를 보내주시면 확인 후 택배 또는 우편으로 원래 주문하신 정상적인 책을 보내드립니다.
* 반송할 주소 : 강원도 원주시 판부면 매봉길 30-14 1층 의방서원
반송하실 때, 파본 도서의 경우 인쇄되지 않은 페이지나, 중복된 페이지, 찢어진 부분 등 구체적인 파본 부분을 포스트잇이나 메모지에 적어 표시해 주시면 감사하겠습니다.
또한 주문번호를 같이 기재해 주시면 주문자 확인 등에 소요되는 시간을 단축할 수 있어 환불이나 교환 등의 사후처리를 보다 빨리 할 수 있습니다.
물론, 반송비용과 재발송 비용은 본사에서 부담합니다.
책을 보내실 때 주문번호와 함께 환불해 드릴 계좌번호를 써서 보내주십시오.
의방서원 회원 약관 및 소비자 보호원 및 공정거래위원회 규정 표준 약관에 근거해 환불이 가능합니다.
하지만 다른 상품과 달리 도서는 상품 외형의 가치보다는 그 속에 담겨 있는 내용에 가치가 있는 것이기 때문에 반품가능 기간이 정해져 있습니다.
반품을 원하시는 도서는 받으신지 5일 이내에 등기우편을 통해 저희 회사로 보내주십시오.
단, 오발송이나 파본된 도서가 아닌 경우에는 배송 비용은 회원님께서 부담하셔야 합니다. 환불시 배송비용을 제외하고 난 후 송금해 드립니다.
이렇게 보내주신 책은 저희 반송 담당자의 확인을 거친 후 환불 처리되게 됩니다. 구체적인 반품 과정은 아래와 같습니다.
1. 전화 033-745-8879 연락 후
반품/교환 문의를 통해 반품하실 도서명을 저희에게 알려 주신 후 등기우편으로 보내주시면 됩니다.
2. 반품하실 주소는 위의 반송 주소와 동일합니다.
3. 보내실 때 반품 도서의 주문번호와 환불해 드릴 계좌번호를 메모지에 적어 함께 넣어주시기 바랍니다.
이러한 메모가 있는 경우에 보다 신속하게 반품 처리가 될 수 있습니다.
무통장 입금계좌
국민은행 303-01-0446-599
즐겨찾기
고객센터
